BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zerem E, Kunosic S, Kurtcehajic A, Zerem D, Zerem O. Bile acids in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2025; 17(8): 108606 [PMID: 40901599 DOI: 10.4254/wjh.v17.i8.108606]
URL: https://www.wjgnet.com/1948-5182/full/v17/i8/108606.htm
Number Citing Articles
1
Ina Bergheim, Jean Francois Cadranel, Jianguo Chen, Wenxing Ding, Robert Eferl, Carmen Garcia-Ruiz, Hartmut Jaeschke, Firouzeh Kazerouni, Amedeo Lonardo, Derek A. Mann, Nahum Méndez-Sánchez, Camelia Mokhtari, Han Moshage, Chiara Raggi, Pavel Strnad, Oren Tirosh, Honoré Tegwende Zougmore, Jose C Fernandez-Checa. Understanding liver and digestive diseases: a paved road to improve diagnosis, management, and treatmentExploration of Digestive Diseases 2026; 5 doi: 10.37349/edd.2026.1005110
2
Yingchun Liang, Shuxin Si, Ruicheng Gao, Bohan Lin, Yong Wei, Zhong Wu, Jinbei Huang, Zijian Zhou. Multi-omics reveals that chenodeoxycholic acid promotes calcium oxalate kidney stone formation by targeting catalaseThe Journal of Nutritional Biochemistry 2026; : 110379 doi: 10.1016/j.jnutbio.2026.110379
3
Yan Li, Yuyuan Hu, Yuan He, Yuhang Yang, Dingwen Xue, Erkui Xue, Jinghan Jia, Wei Zhang, Jinxi Wang. Loss of immunometabolic adaptability in MASH: gut-derived signals drive macrophage reprogramming and fibrosisFrontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1793092
4
Mirjana Grocic, Madison Nguyen, Arun J. Sanyal. Current Trends in the Epidemiology of Obesity and the Association Between Obesity and Metabolic Liver Disease (MASLD/MASH)Diabetes, Obesity and Metabolism 2026; 28(S2): 3 doi: 10.1111/dom.70662
5
Huiru Liu, Songsong Wang, Na Wang, Fang Wang, Jin Ren, Zirong Zhou, Kairui Liu, Xinyan Wang, Yubo Li, Chunsheng Fu, Liwen Han. Mechanisms and key active ingredients of HeDan capsules in ameliorating MASLD via bile acid metabolism regulationJournal of Ethnopharmacology 2026; 366: 121639 doi: 10.1016/j.jep.2026.121639
Write to the Help Desk